Physician profile
Irma Marriott
NPI 1467758730
$740.38
in general payments reported to CMS, 2019-2025
14 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $39.68 · 2023: $225 · 2024: $214 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $110.21 | 2023-2024 | Myfembree |
| Evofem Biosciences, INC. | $95.83 | 2022-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $82.08 | 2025 | Paragard T 380a |
| Organon LLC | $73.96 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $73.09 | 2025 | Veozah |
| Exeltis, USA INC. | $64.55 | 2023-2024 | Slynd |
| Hologic Sales and Service, LLC | $40.83 | 2024-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Avion Pharmaceuticals | $37.06 | 2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $36.85 | 2023 | |
| Abbvie INC. | $33.25 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.86 | 2023 | |
| Aspira Women'S Health INC | $24.07 | 2024 | Ova1 |
| Mylan Pharmaceuticals INC. | $20.66 | 2022 | |
| Pfizer INC. | $16.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irma Marriott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.